VRS
ALDR

Virginia Retirement Systems’s Alder Biopharmaceuticals ALDR Stock Holding History

Virginia Retirement Systems’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-59,700
Closed -$994K – 1157
2018
Q3 		$994K Sell
59,700
-10,100
-14% -$183K 0.01% 711
2018
Q2 		$1.1M Sell
69,800
-53,400
-43% -$811K 0.01% 654
2018
Q1 		$1.56M Sell
123,200
-26,700
-18% -$386K 0.02% 519
2017
Q4 		$1.72M Sell
149,900
-15,400
-9% -$172K 0.02% 520
2017
Q3 		$2.02M Buy
+165,300
New +$1.72M 0.02% 501

Other funds holding ALDR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Virginia Retirement Systems's ALDR Position: Q4 2018 in Review

Virginia Retirement Systems sold out of Alder Biopharmaceuticals (ALDR) in Q4 2018, closing a stake of 59,700 shares — an estimated $994K sold.

Virginia Retirement Systems first reported a position in ALDR in Q3 2017 and held it in 5 quarters. The position peaked at $2.02M in Q3 2017. 124 funds tracked by Wall St. Rank hold ALDR as of Q4 2018.

  • Virginia Retirement Systems reported no remaining Alder Biopharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Virginia Retirement Systems sold 59,700 Alder Biopharmaceuticals shares in Q4 2018, an estimated $994K.
  • Virginia Retirement Systems first reported a position in Alder Biopharmaceuticals in Q3 2017 and held it in 5 quarters.
  • Virginia Retirement Systems's Alder Biopharmaceuticals position peaked at $2.02M in Q3 2017.
  • 124 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2018.

Based on Virginia Retirement Systems's 13F filing for Q4 2018, filed 7 Feb 2019.